| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Perrigo Co Plc (PRGO) has 20 insiders with recent SEC Form 4 filings, including 5 buys and 6 sells. PRGO is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 85.8K | $1.00M | - | |
| CFO | 57.6K | $674.6K | - | |
| Dir | 32.4K | $379.2K | - | |
| VP | 31.3K | $366.7K | - | |
| Dir | 30.6K | $358.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 | Lockwood-Taylor Patrick48 | CEO | Buy | 11,000 | $28.99 | $318,868.00 | New | +12.1% | -7.2% | |
| Nov 14, 2023 | Bezerra Eduardo Guarita45 | EVP &Chief Financial Officer | Buy | 5,000 | $29.18 | $145,881.50 | +145.9% | +12.1% | -7.2% | |
| Jun 13, 2023 | Parker Geoffrey M.47 | Director | Buy | 10,000 | $33.06 | $330,637.00 | +63.0% | +3.1% | -15.9% | |
| May 23, 2023 | Andersen Svend47 | EVP &President Chci | Buy | 2,900 | $33.41 | $96,902.34 | +4.4% | +13.9% | -11.4% | |
| May 11, 2023 | Kessler Murray S | CEO | Sell | 197,646 | $35.75 | $7,066,358.38 | -98.7% | +9.7% | -13.5% | |
| Mar 13, 2023 | Farrington Thomas | EVP And CIO | Sell | 3,723 | $35.57 | $132,434.63 | -38.9% | -6.4% | -13.4% | |
| Mar 10, 2023 | Dillard James E III | EVP &President Csca | Sell | 9,000 | $35.70 | $321,309.00 | -26.4% | -6.1% | -15.6% | |
| Mar 8, 2023 | Janish Ronald Craig61 | EVP, Gbl Ops &Sc &CTO | Sell | 4,500 | $36.92 | $166,133.25 | -18.2% | -9.5% | -19.9% | |
| Mar 6, 2023 | Parker Geoffrey M.47 | Director | Buy | 5,000 | $38.05 | $190,270.00 | +46.0% | -10.6% | -26.2% | |
| Dec 16, 2022 | Quinn Grainne | EVP, Chief Medical Officer | Sell | 2,368 | $31.65 | $74,947.20 | -20.6% | +13.3% | -7.2% |